Medhat Chowdhury
Detroit, MINPI 1386139988
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,806 of the $8,280 with a category attached, or 82.2%. 26 manufacturers reported payments, led by Abbott at 43.2% of the total. 2025 is the largest year on record at $5,177, more than ten times the $496 reported in 2022.
Across 137 payments — averaging $60.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Amgen$793
- Shockwave Medical, Inc$557
- Abiomed$376
- Stryker$373
- Kestra Medical Technology Services, Inc.$350
- plus $2K from 20 others
What the payments were for
- Travel & lodging$1,47418%
- Food & beverage$6,80682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 44 | $3,574 |
| Amgen | 10 | $793 |
| Shockwave Medical, Inc | 13 | $557 |
| Abiomed | 5 | $376 |
| Stryker | 5 | $373 |
| Kestra Medical Technology Services, Inc. | 6 | $350 |
| Boehringer Ingelheim | 5 | $265 |
| Chiesi USA, Inc. | 11 | $248 |
| Boston Scientific | 2 | $234 |
| Sanofi | 2 | $233 |
| Medtronic | 7 | $222 |
| Inari Medical, Inc. | 1 | $163 |
| Edwards Lifesciences | 6 | $145 |
| Penumbra, Inc. | 1 | $143 |
| Novo Nordisk | 1 | $117 |
| Philips North America LLC | 1 | $111 |
| Teleflex LLC | 4 | $83 |
| AstraZeneca | 3 | $65 |
| Pfizer | 3 | $60 |
| Imperative Care, Inc | 1 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $37 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Heartflow, Inc. | 1 | $21 |
| Bayer | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$1,521
- Repatha$745
- ENSITE$375
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$319
- Assure WCD$172
- FlowTriever$168
- CT THROMBECTOMY SYSTEM KIT$163
- FLOWTRIEVER CATHETER, S$163
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$154
- FABRAZYME$150
- CARDIOMEMS$148
- ENSITE PRECISION$145
- Penumbra System$143
- CLOTTRIEVER BOLD CATHETER$140
- XIENCE SKYPOINT$128
- GENERAL VASCULAR ACCESS$123
- Ozempic$117
- JARDIANCE$115
- WATCHMAN FLX$111
- (5027) Intact Vascular Undivided$111
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $155 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.